Aurobindo Pharma consolidated net profit rises 22.77% in the June 2020 quarter
Sales rise 8.93% to Rs 5835.23 crore
Net profit of Aurobindo Pharma rose 22.77% to Rs 780.58 crore in the quarter ended June 2020 as against Rs 635.83 crore during the previous quarter ended June 2019. Sales rose 8.93% to Rs 5835.23 crore in the quarter ended June 2020 as against Rs 5356.84 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales5835.235356.84 9 OPM %21.3421.40 -PBDT1339.871117.00 20 PBT1084.35876.14 24 NP780.58635.83 23Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 13 2020 | 8:53 AM IST